Association study of common variants in the sFRP1 gene region and parameters of bone strength and body composition in two independent healthy Caucasian male cohorts

Molecular Genetics and Metabolism

Volumn 105, Issue 3, 2012, Pages 508-515

  Boudin, Eveline ^a   Piters, Elke ^a   Fransen, Erik ^a   Nielsen, Torben Leo ^b   Andersen, Marianne ^b   Roef, Greet ^c   Taes, Youri ^c   Brixen, Kim ^b   Van Hul, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Association study; Obesity; Osteoporosis; SFRP1; Wnt signaling

Indexed keywords

SECRETED FRIZZLED RELATED PROTEIN 1;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE STRENGTH; CAUCASIAN; CLINICAL TRIAL; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST HIP RATIO;

ADIPOSITY; ADULT; AGED; BELGIUM; BODY COMPOSITION; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; COHORT STUDIES; DENMARK; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

MUS;

EID: 84858297963     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.11.189     Document Type: Article

References (48)

1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 1993, 94:646-650.
2. Osteoporosis prevention, diagnosis, and therapy. NIH Consens. Statement 2000, 17:1-45.
3. Peacock M., Turner C.H., Econs M.J., Foroud T. Genetics of osteoporosis. Endocr. Rev. 2002, 23:303-326.
4. Ferrari S. Human genetics of osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 2008, 22:723-735.
5. Chen Y., Shen H., Yang F., Liu P.Y., Tang N., Recker R.R., Deng H.W. Choice of study phenotype in osteoporosis genetic research. J. Bone Miner. Metab. 2009, 27:121-126.
6. Crabtree N., Lunt M., Holt G., Kroger H., Burger H., Grazio S., Khaw K.T., Lorenc R.S., Nijs J., Stepan J., Ja Falch, Miazgowski T., Raptou P., Ha Pols, Dequeker J., Havelka S., Hoszowski K., Jajic I., Czekalski S., Lyritis G., Silman A.J., Reeve J. Hip geometry, bone mineral distribution, and bone strength in European men and women: the epos study. Bone 2000, 27:151-159.
7. Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., Taketo M.M., Long F., Mcmahon A.P., Lang R.A., Karsenty G. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 2005, 8:751-764.
8. Krishnan V., Bryant H.U., Macdougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 2006, 116:1202-1209.
9. Piters E., Boudin E., Van Hul W. WNT signaling: a win for bone. Arch. Biochem. Biophys. 2008, 473:112-116.
10. Ferrari S.L., Deutsch S., Choudhury U., Chevalley T., Bonjour J.P., Dermitzakis E.T., Rizzoli R., Antonarakis S.E. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am. J. Hum. Genet. 2004, 74:866-875.
11. Brixen K., Beckers S., Peeters A., Piters E., Balemans W., Nielsen T.L., Wraae K., Bathum L., Brasen C., Hagen C., Andersen M., Van Hul W., Abrahamsen B. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the odense androgen study. Calcif. Tissue Int. 2007, 81:421-429.
12. Uitterlinden A.G., Arp P.P., Paeper B.W., Charmley P., Proll S., Rivadeneira F., Fang Y., Van Meurs J.B., Britschgi T.B., Latham J.A., Schatzman R.C., Pols H.A., Brunkow M.E. Polymorphisms in the sclerosteosis/van Buchem disease gene (sost) region are associated with bone-mineral density in elderly whites. Am. J. Hum. Genet. 2004, 75:1032-1045.
13. Rivadeneira F., Styrkarsdottir U., Estrada K., Halldorsson B.V., Hsu Y.H., Richards J.B., Zillikens M.C., Kavvoura F.K., Amin N., Aulchenko Y.S., Cupples L.A., Deloukas P., Demissie S., Grundberg E., Hofman A., Kong A., Karasik D., Van Meurs J.B., Oostra B., Pastinen T., Pols H.A., Sigurdsson G., Soranzo N., Thorleifsson G., Thorsteinsdottir U., Williams F.M., Wilson S.G., Zhou Y., Ralston S.H., Van Duijn C.M., Spector T., Kiel D.P., Stefansson K., Ioannidis J.P., Uitterlinden A.G. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 2009, 41:1199-1206.
14. Van Meurs J.B., Rivadeneira F., Jhamai M., Hugens W., Hofman A., Van Leeuwen J.P., Pols H.A., Uitterlinden A.G. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J. Bone Miner. Res. 2006, 21:141-150.
15. Sims A.M., Shephard N., Carter K., Doan T., Dowling A., Duncan E.L., Eisman J., Jones G., Nicholson G., Prince R., Seeman E., Thomas G., Wass J.A., Brown M.A. Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes. J. Bone Miner. Res. 2008, 23:499-506.
16. Van Meurs J.B., Trikalinos T.A., Ralston S.H., Balcells S., Brandi M.L., Brixen K., Kiel D.P., Langdahl B.L., Lips P., Ljunggren O., Lorenc R., Obermayer-Pietsch B., Ohlsson C., Pettersson U., Reid D.M., Rousseau F., Scollen S., Van Hul W., Agueda L., Akesson K., Benevolenskaya L.I., Ferrari S.L., Hallmans G., Hofman A., Husted L.B., Kruk M., Kaptoge S., Karasik D., Karlsson M.K., Lorentzon M., Masi L., Mcguigan F.E., Mellstrom D., Mosekilde L., Nogues X., Pols H.A., Reeve J., Renner W., Rivadeneira F., Van Schoor N.M., Weber K., Ioannidis J.P., Uitterlinden A.G. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 2008, 299:1277-1290.
17. Richards J.B., Kavvoura F.K., Rivadeneira F., Styrkarsdottir U., Estrada K., Halldorsson B.V., Hsu Y.H., Zillikens M.C., Wilson S.G., Mullin B.H., Amin N., Aulchenko Y.S., Cupples L.A., Deloukas P., Demissie S., Hofman A., Kong A., Karasik A., Van Meurs J.B., Oostra B.A., Pols H.A., Sigurdsson G., Thorsteinsdottir U., Soranzo N., Williams F.M., Zhou Y., Ralston S.H., Thorleifsson G., Van Duijn C.M., Kiel D.P., Stefansson K., Uitterlinden A.G., Ioannidis J.P., Spector T.D. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann. Intern. Med. 2009, 151:528-537.
18. Styrkarsdottir U., Halldorsson B.V., Gretarsdottir S., Gudbjartsson D.F., Walters G.B., Ingvarsson T., Jonsdottir T., Saemundsdottir J., Snorradottir S., Center J.R., Nguyen T.V., Alexandersen P., Gulcher J.R., Eisman J.A., Christiansen C., Sigurdsson G., Kong A., Thorsteinsdottir U., Stefansson K. New sequence variants associated with bone mineral density. Nat. Genet. 2009, 41:15-17.
19. J. Kumar, M. Swanberg, F. Mcguigan, M. Callreus, P. Gerdhem, K. Akesson, Lrp4 association to bone properties and fracture and interaction with genes in the wnt- and bmp signaling pathways, Bone 49 (2011) 343-348.
20. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001, 411:321-325.
21. Itasaki N., Jones C.M., Mercurio S., Rowe A., Domingos P.M., Smith J.C., Krumlauf R. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 2003, 130:4295-4305.
22. Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., Harris S.E., Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 2005, 280:19883-19887.
23. Semenov M., Tamai K., He X. Sost is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 2005, 26770-26775.
24. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 2003, 116:2627-2634.
25. Bodine P.V., Billiard J., Moran R.A., Ponce-de-leon H., Mclarney S., Mangine A., Scrimo M.J., Bhat R.A., Stauffer B., Green J., Stein G.S., Lian J.B., Komm B.S. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J. Cell. Biochem. 2005, 96:1212-1230.
26. Bodine P.V., Stauffer B., Ponce-de-leon H., Bhat B., Mangine A., Seestaller-wehr L.M., Moran R.A., Billiard J., Fukayama S., Komm B.S., Pitts K., Krishnamurthy G., Gopalsamy A., Shi M., Kern J.C., Commons T.J., Wilson M.A., Welmaker G.S., Trybulski E.J., Moore W.J. A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein (sFRP)-1 stimulates bone formation. J. Bone Miner. Res. 2007, 22:s4.
27. Bodine P.V., Zhao W., Kharode Y.P., Bex F.J., Lambert A.J., Goad M.B., Gaur T., Stein G.S., Lian J.B., Komm B.S. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 2004, 18:1222-1237.
28. W. Yao, Z. Cheng, M. Shahnazari, W. Dai, M.L. Johnson, N.E. Lane, Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects, J. Bone Miner. Res. 25 (2010) 190-199.
29. Babij P., Zhao W., Small C., Kharode Y., Yaworsky P.J., Bouxsein M.L., Reddy P.S., Bodine P.V., Robinson J.A., Bhat B., Marzolf J., Moran R.A., Bex F. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 2003, 18:960-974.
30. Akhter M.P., Wells D.J., Short S.J., Cullen D.M., Johnson M.L., Haynatzki G.R., Babij P., Allen K.M., Yaworsky P.J., Bex F., Recker R.R. Bone biomechanical properties in LRP5 mutant mice. Bone 2004, 35:162-169.
31. Ferrari S.L., Deutsch S., Baudoin C., Cohen-solal M., Ostertag A., Antonarakis S.E., Rizzoli R., De Vernejoul M.C. LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone 2005, 37:770-775.
32. Zhang Z.L., Qin Y.J., He J.W., Huang Q.R., Li M., Hu Y.Q., Liu Y.J. Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in postmenopausal Chinese women. Acta Pharmacol. Sin. 2005, 26:1111-1116.
33. Kiel D.P., Ferrari S.L., Cupples L.A., Karasik D., Manen D., Imamovic A., Herbert A.G., Dupuis J. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone 2007, 40:587-596.
34. Ohnaka K., Yamamoto K., Nakamura K., Adachi M., Kawate H., Kono S., Takayanagi R. Association of single nucleotide polymorphisms in secreted frizzled-related protein 1 gene with bone mineral density in Japanese women. Geriatr. Gerontol. Int. 2009, 9:304-309.
35. Ling L., Nurcombe V., Cool S.M. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009, 433:1-7.
36. H. taipaleenmaki, B.M. Abdallah, A Aldahmash,A.M. Saamanen, M. Kassem, WNT signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations, Exp. Cell Res. 317 (2011) 745-756.
37. C. Lagathu, C. Christodoulides, C.Y. Tan, S. Virtue, M. Laudes, M. Campbell, K. Ishikawa, F. Ortega, F.J. Tinahones, J.M. Fernandez-Real, M. Oresic, J.K. Sethi, A vidal-puig, secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity, Int. J. Obes. (Lond.) 34 (2010) 1695-1705.
38. Nielsen T.L., Wraae K., Brixen K., Hermann A.P., Andersen M., Hagen C. Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study. Int. J. Obes. (Lond) 2006, 30:805-815.
39. Lapauw B.M., Taes Y., Bogaert V., Vanbillemont G., Goemaere S., Zmierczak H.G., De Bacquer D., Kaufman J.M. Serum estradiol is associated with volumetric BMD and modulates the impact of physical activity on bone size at the age of peak bone mass: a study in healthy male siblings. J. Bone Miner. Res. 2009, 24:1075-1085.
40. Bogaert V., Taes Y., Konings P., Van Steen K., De Bacquer D., Goemaere S., Zmierczak H., Crabbe P., Kaufman J.M. Heritability of blood concentrations of sex-steroids in relation to body composition in young adult male siblings. Clin. Endocrinol. (Oxf) 2008, 69:129-135.
41. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 2004, 74:765-769.
42. Lettre G., Lange C., Hirschhorn J.N. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet. Epidemiol. 2007, 31:358-362.
43. Purcell S., Neale B., Todd-brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
44. S. Li, J.H. Zhao, J. Luan, R.N. Luben, S.A. Rodwell, K.T. Khaw, K.K. Ong, N.J. Wareham, R.J. Loos, Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies, Am. J. Clin. Nutr. 91 (2010) 184-190.
45. Rivadeneira F., Zillikens M.C., De Laet C.E., Hofman A., Uitterlinden A.G., Beck T.J., Pols H.A. Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam study. J. Bone Miner. Res. 2007, 22:1781-1790.
46. W.F. Li, S.X. Hou, B. Yu, M.M. Li, C. Ferec, J.M. Chen, Senetics of osteoporosis: accelerating pace in gene identification and validation, Hum. Genet. 127 (2010) 249-285.
47. Shen H., Liu Y., Liu P., Recker R.R., Deng H.W. Nonreplication in genetic studies of complex diseases - lessons learned from studies of osteoporosis and tentative remedies. J. Bone Miner. Res. 2005, 20:365-376.
48. Bonnick S.L. HSA: beyond BMD with DXA. Bone 2007, 41:s9-s12.